Sales and Marketing
FDA urges close monitoring of COVID-19 patients treated with hydroxychloroquine
April 27, 2020 Sales and Marketing COVID-19, FDA, chloroquine, coronavirus, hydroxychloroquine
European Medicines Agency’s review of Picato finds its risks outweigh its benefits
April 24, 2020 Business Services, Medical Communications, Sales and Marketing
FDA approves Immunomedics’ Trodelvy for metastatic triple-negative breast cancer one month ahead of schedule
April 23, 2020 Sales and Marketing Cancer, Immunomedics, Trodelvy, breast cancer, pharma
Boehringer’s nintedanib approved in Europe for systemic sclerosis-associated interstitial lung disease
April 22, 2020 Research and Development, Sales and Marketing Boehringer Ingelheim, EU, nintedanib, pharma
AbbVie’s Imbruvica scoops up 11th FDA approval with chronic lymphocytic leukaemia/small lymphocytic lymphoma nod
April 22, 2020 Research and Development, Sales and Marketing Cancer, FDA, imbruvica, leukaemia
Bayer’s Vitrakvi becomes first tumour-agnostic therapy approved by NICE for NHS patients with NTRK fusion+ cancer
April 21, 2020 Manufacturing and Production, Sales and Marketing Bayer, Cancer, NICE, UK, Vitrakvi, tumour agnostic
How the intended role of generic medicines is being undermined in America
April 20, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Drug pricing, US, feature, generic medicines, generics
Novartis to sponsor large clinical trial of hydroxychloroquine in COVID-19 patients
April 20, 2020 Sales and Marketing COVID19 Coronavirus, coronavirus, covid19
Gilead’s remdesivir significantly reduces COVID-19 symptoms in rhesus monkeys in NIH trial
April 20, 2020 Business Services, Medical Communications, Sales and Marketing COVID-19, Gilead, National Institutes of Health, coronavirus, remdesivir
English COVID-19 cases to be tracked by ethnicity
April 20, 2020 Sales and Marketing African-Americans, BAME, COVID-19, coronavirus
Incyte’s Pemazyre becomes FDA’s first and only approved unresectable, advanced cholangiocarcinoma treatment
April 20, 2020 Sales and Marketing FDA, Incyte, pharma
Hydroxychloroquine fails COVID-19 clinical trial in France
April 20, 2020 Sales and Marketing COVID-19, chloroquine, coronavirus, hydroxychloroquine
Top Ten most popular articles on Pharmafile.com this week
April 17, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus, top 10
FDA approves UroGen’s Jelmyto as first therapy for low-grade upper tract urothelial cancer
April 16, 2020 Sales and Marketing Cancer, FDA, Jelmyto, UroGen Pharma, pharma, urothelial cancer
Scottish Medicines Consortium approves new drugs in multiple sclerosis, ulcerative colitis and diabetes
April 15, 2020 Research and Development, Sales and Marketing Biogen, Fambyra, Janssen, NHS, Rimzoic, Sandoz, Sanofi, Scotland, Scottish Medicines Consortium, Stelara, Suliqua, pharma
Latest content
Recruitment experts hired in search for new CGT Catapult chief
Envirogen secures place on NHS Scotland reverse osmosis framework
